key: cord-0761901-hhbvg9h0
authors: Tan, Geak Poh; Ho, Sharlene; Fan, Bingwen Eugene; Chotirmall, Sanjay H.; Tan, Cher Heng; Lew, Sennen Jin Wen; Chia, Po Ying; Young, Barnaby E.; Abisheganaden, John Arputhan; Puah, Ser Hon
title: Reversible platypnea-orthodeoxia in COVID-19 acute respiratory distress syndrome survivors
date: 2020-08-07
journal: Respir Physiol Neurobiol
DOI: 10.1016/j.resp.2020.103515
sha: 55f31d7d46dce50b0ff08048a1b3b96f2d636479
doc_id: 761901
cord_uid: hhbvg9h0

Platypnea-orthodeoxia syndrome (POS) is a rare clinical syndrome characterized by orthostatic oxygen desaturation and positional dyspnea from supine to an upright position. We observed POS in 5 of 20 cases of severe 2019 novel coronavirus (COVID-19) pneumonia, which demonstrated persistently elevated shunt fraction even after liberation from mechanical ventilation. POS was first observed during physiotherapy sessions; median oxygen desaturation was 8% (range: 8-12%). Affected individuals were older (median 64 vs 53 years old, p = 0.05) and had lower body mass index (median 24.7 vs 27.6 kg/m (Radermacher et al., 2017), p = 0.03) compared to those without POS. While POS caused alarm and reduced tolerance to therapy, this phenomenon resolved over a median of 17 days with improvement of parenchymal disease. The mechanisms of POS are likely due to gravitational redistribution of pulmonary blood flow resulting in increased basal physiological shunting and upper zone dead space ventilation due to the predominantly basal distribution of consolidative change and reported vasculoplegia and microthrombi in severe COVID-19 disease.

 POS is likely a gravitational exacerbation of intrapulmonary shunt in acute respiratory distress syndrome due to COVID-19 related vasculopathy and increased wasted ventilation.

 POS may cause alarm, reduces tolerance to physiotherapy and requires adjustment in the approach to rehabilitation during the recovery period.

Platypnea-orthodeoxia syndrome (POS) is a rare clinical syndrome characterized by orthostatic oxygen desaturation and positional dyspnea from supine to an upright position. We observed POS in 5 of 20 cases of severe 2019 novel coronavirus pneumonia, which demonstrated persistently elevated shunt fraction even after liberation from mechanical ventilation. POS was first observed during physiotherapy sessions; median oxygen desaturation was 8% (range: 8-12%). Affected individuals were older (median 64 vs 53 years old, p=0.05) and had lower body mass index (median 24.7 vs 27.6 kg/m 2 , p=0.03) compared to those without POS. While POS caused alarm and reduced tolerance to therapy, this phenomenon resolved over a median of 17 days with improvement of parenchymal disease. The mechanisms of POS are likely due to gravitational redistribution of pulmonary blood flow resulting in increased basal physiological shunting and upper zone dead space ventilation due to the predominantly basal distribution of J o u r n a l P r e -p r o o f INTRODUCTION Platypnea-orthodeoxia syndrome (POS) is a rare clinical syndrome characterized by orthostatic dyspnea and a measurable drop in arterial oxygen saturation of >5% or a PaO2 >4mmHg (1) . At our centre, we observed the novel finding of POS in patients with severe 2019 novel coronavirus disease , and, therefore aim to describe the clinical characteristics and outcome of these affected individuals.

We retrospectively reviewed medical records of all severe COVID-19 cases admitted to the intensive care unit (ICU) at the National Centre for Infectious Diseases (NCID), Singapore over a 4-month period (29/01/2020 to 29/05/2020). Only individuals with POS who survived the ICU stay were included for analysis. Patients who did not require invasive mechanical ventilation (IMV) or admitted to the ICU for non-respiratory complications were excluded. The baseline characteristics, physiology, ventilator settings and the outcomes of ICU stay are described and compared to cases without POS. Informed consent and institutional ethics board review were waived under the provision of the Infectious Disease Act, Singapore.

Thirty-five patients received IMV for respiratory failure during the study period: (Table 1) .

To the best of our knowledge, we report the first observations of POS following severe COVID-19 ARDS. Although often attributed to right-to-left intracardiac shunting, POS occurs in settings of increased venous admixture secondary to intrapulmonary anatomical (e.g. pulmonary arteriovenous malformation) or rarer physiological pulmonary shunts, due to basalpredominant parenchymal diseases (1). Our patients fulfilled criteria for moderate-severe ARDS. Venous admixture or intrapulmonary shunting is a recognized pathophysiological mechanism of hypoxemia in ARDS (2). However, the underlying mechanisms of POS, particularly in the context of severe COVID-19 illness are likely more complex. Alveolar hypoventilation has a role, for instance by increasing the proportion of 'wasted' ventilation (zone 1 phenomenon) which is compounded by reduced cardiac output, and an imbalanced load-capacity conferred by reduced lung compliance and critical illness myopathy ( Figure 2 ) (2) (3) (4) (5) . Zone 1 phenomenon is also exaggerated in the presence of microthrombi, and microangiopathy observed in severe COVID-19 disease (6) . This could explain the disparity in severity of symptoms where individuals with the worst dyspnea had highest D-dimer levels ( Figure 1 ). Therefore, we hypothesize that POS is a gravitational exacerbation of intrapulmonary shunt in ARDS due to COVID-19 related vasculopathy and increased wasted ventilation. The main limitations of our clinical findings are the lack of definitive exclusion of intra-cardiac anatomical shunting, e.g. by contrast-enhanced echocardiography or scintigraphy with macroaggregated albumin. In our institution, these tests present logistical challenges in a negative pressure isolation setting. While present in one-fifth of ARDS patients, we believe that the likelihood of patent foramen ovale is low due to: 1) the absence of paradoxical hypoxemia despite incremental PEEP, 2) no obvious chamber enlargement on bedside echocardiography, and 3) eventual resolution of POS over time (7) . Hepatopulmonary shunting was also unlikely with normal liver function.

As of 29 th May 2020, Singapore has seen 33,860 COVID-19 cases (8). Our centre managed 42 of 113 (37%) patients who required ICU care. POS is notably a shared feature in a quarter of our COVID-19 ICU survivors, and may be a feature of older patients with more severe COVID-19 disease and/or inflammation. The reported finding of peripheral and dependent consolidation in more severely ill patients on sequential CT scans is also observed in our patients (9) . POS is rarely reported post-ARDS, illustrating a potential key observation in severe . Of note, however, exercise-related oxygen desaturation, which shares some key pathophysiological mechanisms to orthodeoxia is described post-ARDS, and, POS may represent a more severe form of exertional desaturation (4, 10) . In our experience, detecting POS in the late or post-ICU setting following severe COVID-19 illness likely reflects the increased physiotherapy-related 

The multiple dimensions of

Platypnea Orthodeoxia syndrome: A review

Fifty years of research in ARDS. Gas exchange in acute respiratory distress syndrome

Nunn's applied respiratory physiology

Sequelae of the adult respiratory distress syndrome

Cardiac Output and Minute Ventilation During Exercise

Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series rom New Orleans

Prevalence and prognosis of shunting across patent foramen ovale during acute respiratory distress syndrome

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study

One-year outcomes in survivors of the acute respiratory distress syndrome

FiO 2 ratio

Baseline investigation C-reactive protein

PAO 2 -PaO 2 , mmHg Before intubation 522

Duration of IMV, days

Data is described as median (range) and count (percentage)

* Procalcitonin was measured on ICU presentation in 3 (60%) and 14 (93%) of individuals with POS and without POS respectively

LDH: lactate dehydrogenase, PaCO 2 -PETCO 2 : carbon dioxide partial pressure difference between arterial blood and end-tidal gas, PAO 2 -PaO 2 : oxygen partial pressure difference between alveolar gas and arterial blood